Christopher White
Corporate Officer/Principal bei OCULAR THERAPEUTIX, INC.
Vermögen: 519 494 $ am 30.04.2024
Profil
Christopher G.
White's current job is Chief Business Officer at Ocular Therapeutix, Inc. His former jobs include being a Partner-Pharmaceutical & Medical Products Practice at Accenture Ltd.
from 2005 to 2007, VP, Partner-Pharmaceuticals & Healthcare Practice at A.T.
Kearney, Inc. from 1998 to 2005, Chief Business Officer & Senior Vice President at AMAG Pharmaceuticals, Inc. from 2007 to 2014, Chief Operating Officer at Silver Creek Pharmaceuticals, Inc., Chief Business Officer at Entasis Therapeutics, Inc., and President & Chief Operating Officer at Sofregen Medical, Inc. Mr. White holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from Tufts University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
OCULAR THERAPEUTIX INC
0,08% | 05.02.2024 | 123 689 ( 0,08% ) | 519 494 $ | 30.04.2024 |
Aktive Positionen von Christopher White
Unternehmen | Position | Beginn |
---|---|---|
OCULAR THERAPEUTIX, INC. | Corporate Officer/Principal | 11.07.2019 |
Ehemalige bekannte Positionen von Christopher White
Unternehmen | Position | Ende |
---|---|---|
AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 11.07.2014 |
Accenture Ltd.
Accenture Ltd. Miscellaneous Commercial ServicesCommercial Services Accenture Ltd. provides services to management consulting, technology services and outsourcing organizations. It provides management consulting, technology, systems integration and outsourcing services and solutions to the communications, electronics, high technology, media and entertainment industries. The company was founded in 1984 and is headquartered in Hamilton, Bermuda. | Corporate Officer/Principal | - |
A.T. Kearney, Inc.
A.T. Kearney, Inc. Miscellaneous Commercial ServicesCommercial Services A.T. Kearney, Inc. engages in the provision of management consulting services. Its services include strategic, operational and technology consulting executive search services. The company was founded by Andrew Thomas Kearney in 1926 and is headquartered in Chicago, IL. | Corporate Officer/Principal | - |
Silver Creek Pharmaceuticals, Inc.
Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Geschäftsführer | - |
Sofregen Medical, Inc.
Sofregen Medical, Inc. BiotechnologyHealth Technology Sofregen Medical, Inc. develops innovative silk-based solutions for soft tissue defects. Its products: SERI silk derived surgical scaffold is knitted scaffold made from ultra-pure, sterile, silk-derived bioprotein that facilitates neovascularization and native tissue regeneration over time and Sofregen technology a silk derived material for medical application. The company was founded by Anh Hoang and Howard J. Weisman on May 19, 2014 and is headquartered in Cambridge, MA. | Präsident | - |
Ausbildung von Christopher White
The Trustees of Columbia University in The City of New York | Masters Business Admin |
Tufts University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
OCULAR THERAPEUTIX, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Accenture Ltd.
Accenture Ltd. Miscellaneous Commercial ServicesCommercial Services Accenture Ltd. provides services to management consulting, technology services and outsourcing organizations. It provides management consulting, technology, systems integration and outsourcing services and solutions to the communications, electronics, high technology, media and entertainment industries. The company was founded in 1984 and is headquartered in Hamilton, Bermuda. | Commercial Services |
A.T. Kearney, Inc.
A.T. Kearney, Inc. Miscellaneous Commercial ServicesCommercial Services A.T. Kearney, Inc. engages in the provision of management consulting services. Its services include strategic, operational and technology consulting executive search services. The company was founded by Andrew Thomas Kearney in 1926 and is headquartered in Chicago, IL. | Commercial Services |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Health Technology |
Sofregen Medical, Inc.
Sofregen Medical, Inc. BiotechnologyHealth Technology Sofregen Medical, Inc. develops innovative silk-based solutions for soft tissue defects. Its products: SERI silk derived surgical scaffold is knitted scaffold made from ultra-pure, sterile, silk-derived bioprotein that facilitates neovascularization and native tissue regeneration over time and Sofregen technology a silk derived material for medical application. The company was founded by Anh Hoang and Howard J. Weisman on May 19, 2014 and is headquartered in Cambridge, MA. | Health Technology |
Silver Creek Pharmaceuticals, Inc.
Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |